Market Overview:
The global risedronate sodiums market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of osteoporosis and other bone disorders, rising geriatric population, and growing demand for minimally invasive treatments. Based on type, the global risedronate sodiums market is segmented into troche and capsule. The capsule segment is expected to account for a larger share of the market in 2018 owing to its ease of use and higher patient compliance rates as compared to troche formulations. Based on application, the global risedronate sodiums market is segmented into hospital, clinic, drugstore, and others (including research institutes). The hospital segment accounted for a larger share of the market in 2017 due to increased utilization rates for treatment of bone disorders in this setting. However, clinics are projected to grow at a faster rate during the forecast period owing to rising demand from patients with chronic diseases who require regular monitoring by specialists.
Product Definition:
A bisphosphonate drug used to prevent and treat osteoporosis. It works by slowing bone loss and building new bone.
Troche:
Troche is a medication used for treating tooth decay in children. It works by killing the bacteria that causes cavity. The most common symptom of tooth decay is pain when eating or drinking hot or cold liquids, sweets, and sugars. This condition may also occur after a dental procedure (dental trauma), which includes dental fillings, root canals, crowns and bridges as well as orthodontic braces.
Capsule:
Capsule is a small package containing medicine or drug. It protects active ingredients from light, moisture, and other external factors that can damage them. Capsules are usually gelatin or plastic-based shells filled with drugs and then closed either by hardening or by fusion with the outer surface.
Rising demand for capsule due to its advantages such as convenience of use, high absorption rate of the contents than oral tablets.
Application Insights:
The global market is segmented by application into hospital, clinic, drugstore and others. The hospital segment dominated the overall industry in terms of revenue in 2017. This can be attributed to the high usage rate of risedronate sodiums for osteoporosis treatment at hospitals worldwide. Furthermore, increasing awareness about osteoporosis among geriatric population groups is also expected to drive demand over the forecast period.
Rising incidences of bone fractures are driving demand for a wide range of medicines including bisphosphonates such as alendronate and etidronate which are used for their anabolic properties that help in healing bones faster than would normally occur naturally.
Regional Analysis:
North America dominated the global risedronate sodiums market in 2017. The growth is attributed to rising product consumption for osteoarthritis treatment and increasing R&D initiatives by key players. In addition, high healthcare expenditure and a growing geriatric population are expected to drive the regional market over the forecast period.
Asia Pacific is expected to witness fastest growth during the forecast period owing to factors such as improving economic conditions, expanding middle-class population base, rising healthcare spending by countries like China and India coupled with growing demand for OTC drugs in these economies will drive this region’s growth over next eight years.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace. This will lead to an increase in the demand for risedronate sodiums, as they are the most effective drugs for treating osteoporosis in this population.
- Growing awareness about osteoporosis: There is a growing awareness about osteoporosis among people all over the world. This will lead to an increase in the demand for risedronate sodiums, as they are the most effective drugs for preventing and treating this condition.
- Rising incidence of fractures: The incidence of fractures is rising globally due to various factors such as aging, lifestyle changes, etc. This will lead to an increased demand for risedronate sodiums, which are highly effective in preventing and treating fractures caused by osteoporosis.
Scope Of The Report
Report Attributes
Report Details
Report Title
Risedronate Sodiums Market Research Report
By Type
Troche, Capsule
By Application
Hospital, Clinic, Drugstore, Others
By Companies
Allergan, Sanofi, Teva Pharmaceuticals USA, Inc., Mylan, Apotex Inc, Macleods Pharmaceuticals Limited, Sun Pharmaceutical Industries Ltd, Beijing SL Pharmaceutical Co.,Ltd., Changzhou Watson Pharmaceuticals Co., Ltd, Allergan
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
201
Number of Tables & Figures
141
Customization Available
Yes, the report can be customized as per your need.
Global Risedronate Sodiums Market Report Segments:
The global Risedronate Sodiums market is segmented on the basis of:
Types
Troche, Capsule
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Drugstore, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan
- Sanofi
- Teva Pharmaceuticals USA, Inc.
- Mylan
- Apotex Inc
- Macleods Pharmaceuticals Limited
- Sun Pharmaceutical Industries Ltd
- Beijing SL Pharmaceutical Co.,Ltd.
- Changzhou Watson Pharmaceuticals Co., Ltd
- Allergan
Highlights of The Risedronate Sodiums Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Troche
- Capsule
- By Application:
- Hospital
- Clinic
- Drugstore
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Risedronate Sodiums Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Risedronate Sodium is a medication used to treat osteoporosis. It works by increasing the amount of bone in the body.
Some of the major companies in the risedronate sodiums market are Allergan, Sanofi, Teva Pharmaceuticals USA, Inc., Mylan, Apotex Inc, Macleods Pharmaceuticals Limited, Sun Pharmaceutical Industries Ltd, Beijing SL Pharmaceutical Co.,Ltd., Changzhou Watson Pharmaceuticals Co., Ltd, Allergan.
The risedronate sodiums market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Risedronate Sodiums Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Risedronate Sodiums Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Risedronate Sodiums Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Risedronate Sodiums Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Risedronate Sodiums Market Size & Forecast, 2018-2028
4.5.1 Risedronate Sodiums Market Size and Y-o-Y Growth
4.5.2 Risedronate Sodiums Market Absolute $ Opportunity
Chapter 5 Global Risedronate Sodiums Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Risedronate Sodiums Market Size Forecast by Type
5.2.1 Troche
5.2.2 Capsule
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Risedronate Sodiums Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Risedronate Sodiums Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Drugstore
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Risedronate Sodiums Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Risedronate Sodiums Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Risedronate Sodiums Analysis and Forecast
9.1 Introduction
9.2 North America Risedronate Sodiums Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Risedronate Sodiums Market Size Forecast by Type
9.6.1 Troche
9.6.2 Capsule
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Risedronate Sodiums Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Drugstore
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Risedronate Sodiums Analysis and Forecast
10.1 Introduction
10.2 Europe Risedronate Sodiums Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Risedronate Sodiums Market Size Forecast by Type
10.6.1 Troche
10.6.2 Capsule
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Risedronate Sodiums Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Drugstore
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Risedronate Sodiums Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Risedronate Sodiums Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Risedronate Sodiums Market Size Forecast by Type
11.6.1 Troche
11.6.2 Capsule
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Risedronate Sodiums Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Drugstore
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Risedronate Sodiums Analysis and Forecast
12.1 Introduction
12.2 Latin America Risedronate Sodiums Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Risedronate Sodiums Market Size Forecast by Type
12.6.1 Troche
12.6.2 Capsule
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Risedronate Sodiums Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Drugstore
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Risedronate Sodiums Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Risedronate Sodiums Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Risedronate Sodiums Market Size Forecast by Type
13.6.1 Troche
13.6.2 Capsule
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Risedronate Sodiums Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Drugstore
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Risedronate Sodiums Market: Competitive Dashboard
14.2 Global Risedronate Sodiums Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Allergan
14.3.2 Sanofi
14.3.3 Teva Pharmaceuticals USA, Inc.
14.3.4 Mylan
14.3.5 Apotex Inc
14.3.6 Macleods Pharmaceuticals Limited
14.3.7 Sun Pharmaceutical Industries Ltd
14.3.8 Beijing SL Pharmaceutical Co.,Ltd.
14.3.9 Changzhou Watson Pharmaceuticals Co., Ltd
14.3.10 Allergan
